Health Canada drug identification number

DIN 02472104 — LONSURF 15 MG; 6.14 MG

LONSURF is a tablet of Tipiracil / Trifluridine marketed by TAIHO PHARMA CANADA, INC.. The full Tipiracil / Trifluridine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02472104
Brand name
LONSURF
Active ingredient
Tipiracil / Trifluridine
Strength
15 MG; 6.14 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
TAIHO PHARMA CANADA, INC.
Health Canada status
MARKETED
Drug class
Antineoplastic agent (thymidine phosphorylase inhibitor / nucleoside metabolic inhibitor)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Tipiracil / Trifluridine products

DINBrandStrengthFormManufacturerStatus
02472112 LONSURF 8.19 MG; 20 MG TABLET TAIHO PHARMA CANADA, INC. MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.